Dr. Mursalin M. Anis, MD

Dr. Anis practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Anis' NPI, 1700013711, was assigned on June 17, 2009. Dr. Anis graduated from Cleveland Medical College, Homeopathic in 2009. Dr. Anis holds Florida license ME135329.

Dr. Anis' primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Anis' primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Anis is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Anis to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anis practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Anis' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Anis is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Anis' licenses on file in 4 states: Florida, New Jersey, Massachusetts and Pennsylvania.

Dmand AI lists larynx and vocal cord disease among the conditions Dr. Anis treats.

CMS data shows 637 Medicare services from Dr. Anis across 10 procedure codes in 2024, for 214 Medicare patients. Medicare paid $54,312 for them.

CMS counts 214 Medicare patients who saw Dr. Anis in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Anis' median patient age at 73, with 48% women.

In 2024, Dr. Anis wrote 184 Medicare Part D claims for 75 patients. 100% of them were for generic drugs. CMS names the drug for 134 of them, across 5 drugs with 11 or more claims each, at $813 in total drug cost. In 2023, CMS named 94 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Anis for performance year 2024, reported as part of a group. Dr. Anis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Anis as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Anis, published from 2007 to 2025. 2018 was the busiest year, with 2. The most frequent topics are Laryngoplasty, Vocal Cord Paralysis and Vocal Cords. Dr. Anis has published most often in J Voice. Dr. Anis' most frequent co-authors are David Edward Rosow, MD, Luke J. Pasick, MD and Daniel Alejandro Benito, MD.

CMS Open Payments shows 5 general payments to Dr. Anis from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Acclarent, Inc paid the most, $113.

Dmand AI lists 1 award for Dr. Anis.

Dr. Anis graduated from Cleveland Medical College, Homeopathic in 2009. Dr. Anis is a member of NHS.

Dr. Anis is in network with 11 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.